Suven Life Sciences Ltd has secured four product patents, three from Australia and one from New Zealand, for its New Chemical Entities. The granted claims of the patents included the class of selective 5-HT compounds discovered by the Hyderabad-based company and being developed as therapeutic agents for treating cognitive impairment associated with neurodegenerative disorders, according to a release.
Suven Life bags four patents
Published on
September 5, 2011 16:32
Tags